Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia Advani, Anjali S. , Larsen, Eric , Laumann, Kristina ... - - Blood Adv - 2021 Manuscript - Secondary - Primary - Leukemia - CALGB-10403 , COG-AALL0232
A Comparison of Outcomes between Adolescents and Young Adults (AYA) and Children with Acute Promyelocytic Leukemia: North American Intergroup Study CALGB 9710 (Alliance) Kutny, Matthew A. , Geyer, Susan , Laumann, Kristina M ... - ASH - Blood - 2014 Abstract - Secondary-not-in-original - Primary - Leukemia - C9710
Outcome for Pediatric Acute Promyelocytic Leukemia Patients at Children’s Oncology Group Sites on the Leukemia Intergroup Study CALGB 9710 (Alliance) Kutny, Matthew A. , Geyer, Susan , Laumann, Kristina M ... - - Pediatr Blood Cancer - 2019 Manuscript - Secondary-not-in-original - Primary - Leukemia - CALGB-9710
Effect of young Age on Outcomes in Pediatric Acute Promyelocytic Leukemia: North American Intergroup Study CALGB 9710 (Alliance) Kutny, Matthew A. , Gregory, John , Geyer, Susan , Laumann, Kristina ... - ASH - Blood - 2014 Abstract - Secondary-not-in-original - Primary - Leukemia - C9710
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era Mantha, Simon , Goldman, Debra A. , Devlin, Sean M. , Lee, Ju-Whei ... - - Blood - 2017 Manuscript - Secondary-not-in-original - Primary - Leukemia - CALGB-9710
Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801 Marcucci, Guido , Geyer, Susan , Laumann, Kristina , Zhao, Weiqiang ... - - Blood Adv - 2020 Manuscript - Primary - Primary - Leukemia - CALGB-10801 , CALGB-20202
Arsenic trioxide in front-line therapy of acute promyelocytic leukemia (C9710): prognostic significance of FLT3 mutations and complex karyotype Poiré, Xavier , Moser, Barry K. , Gallagher, Robert E. ... - - Leuk. Lymphoma - 2014 Manuscript - Secondary-not-in-original - Primary - Leukemia - CALGB-9710
Randomized trial of 10 days of decitabine ± bortezomib in untreated older patients with AML: CALGB 11002 (Alliance) Roboz, Gail J. , Mandrekar, Sumithra J. , Desai, Pinkal ... - - Blood Adv - 2018 Manuscript - Primary - Primary - Leukemia - CALGB-11002
Phase II Trials of Single Agent Anti-VEGF Therapy for Patients with Chronic Lymphocytic Leukemia (CLL) Shanafelt, Tait , Zent, Clive , Byrd, John , Erlichman, Charles ... - - Leuk. Lymphoma - 2010 Manuscript - Primary - Primary - Leukemia - N048F , N0683
An inherited genetic variant in CEP72 promoter predisposes to vincristine-induced peripheral neuropathy in adults with acute lymphoblastic leukemia Stock, Wendy , Diouf, Barthelemy , Crews, Kristine R. , Pei, Deqing ... - - Clin. Pharmacol. Ther. - 2017 Manuscript - Secondary-not-in-original - Meta-Analysis - Leukemia - CALGB-10102 , CALGB-10403 , CALGB-19802 , CALGB-9862
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403 Stock, Wendy , Luger, Selina M. , Advani, Anjali S. , Yin, Jun ... - - Blood - 2019 Manuscript - Primary - Primary - Leukemia - CALGB-10403
Favorable outcomes for adolescents and young adults (AYA) with Acute Lymphoblastic Leukemia (ALL): Early results of US Intergroup trial CALGB 10403 (Alliance) Stock, Wendy , Luger, Selina , Advani, Anjali , Geyer, Susan ... - ASH - Blood - 2014 Abstract - Primary - Preliminary - Leukemia - CALGB-10403
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation Stone, Richard M. , Mandrekar, Sumithra J. , Sanford, Ben L. ... - - N. Engl. J. Med. - 2017 Manuscript - Primary - Primary - Leukemia - CALGB-10603
A phase 2 study incorporating sorafenib into the chemotherapy for older adults with FLT3-mutated acute myeloid leukemia: CALGB 11001 Uy, Geoffrey L. , Mandrekar, Sumithra J. , Laumann, Kristina ... - - Blood Adv - 2017 Manuscript - Primary - Primary - Leukemia - CALGB-11001
Addition of Sorafenib to Chemotherapy Improves the Overall Survival of Older Adults With FLT3-ITD Mutated AML (Alliance C11001). Uy, Geoffrey L. , Mandrekar, Sumithra , Laumann, Kristina ... - ASH - Blood - 2015 Abstract - Primary - Primary - Leukemia - CALGB-11001
A phase II multi-center study of the addition of azacitidine to reduced-intensity conditioning allogeneic transplantation for high-risk myelodysplasia (and older patients with acute myeloid leukemia: CALGB 100801 (Alliance) Vij, Ravi , Le-Rademacher, Jennifer , Laumann, Kristina , Hars, Vera ... - - Biol. Blood Marrow Transplant. - 2019 Manuscript - Primary - Primary - Transplant - CALGB-100801